Mersana Therapeutics, Inc. earnings per share and revenue

MRSN earnings per share for the last quarter are -0.16 USD whereas the estimation was -0.16 USD which accounts for 0.11% surprise. Företagets omsättning för samma period uppgår till 10.70 M USD trots den uppskattade siffran 14.74 M USD. Estimated earnings per share for the next quarter are -0.18 USD, and revenue is expected to reach 8.50 M USD. Also watch annual changes over time to get a bigger picture of MRSN earnings per share and revenue dynamics.